Ubs Group Ag Bluejay Diagnostics, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.19 - $0.41 $980 - $2,114	5,158 New	5,158 $1,000
Q4 2022 Feb 08, 2023	SELL	$0.34 - $138.99 $1,143 - $467,562	-3,364 Reduced 25.06%	10,061 $3,000
Q3 2022 Nov 10, 2022	BUY	$0.83 - $132.53 $10,934 - $1.75 Million	13,174 Added 5248.61%	13,425 $10,000
Q2 2022 Aug 10, 2022	SELL	$0.94 - $1.63 $5,019 - $8,704	-5,340 Reduced 95.51%	251 $0
Q1 2022 May 16, 2022	BUY	$0.86 - $2.92 $496 - $1,684	577 Added 11.51%	5,591 $6,000
Q4 2021 Feb 14, 2022	BUY	$2.33 - $5.32 $11,682 - $26,674	5,014 New	5,014 $13,000

Ticker BJDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,152,300
Market Cap $71.3M
Description
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.